Background. The COVID-19 pandemic has posed significant health risks, particularly for elderly patients. Studies on the impact of COVID-19 in this age group have highlighted various atypical clinical manifestations, complications, and challenges in diagnosis and treatment. The purpose of this article is to explore the distinct features of COVID-19 in elderly individuals and propose effective diagnostic and treatment methods. Materials and Methods. This article analyzes data from 20 clinical studies involving 4,965 elderly patients aged 60 years and older. The studies assess the clinical symptoms, laboratory findings, and complications associated with COVID-19 in older adults. Various diagnostic tools, including polymerase chain reaction (PCR) tests and imaging techniques, are discussed, along with treatment regimens used in these cases. Results. The findings indicate that elderly patients often exhibit atypical clinical signs such as cognitive dysfunction, weakness, and unusual gastrointestinal symptoms. Laboratory results commonly show lymphocytopenia, elevated D-dimer levels, and increased C-reactive protein levels. Complications like acute kidney injury, liver dysfunction, and secondary bacterial infections are prevalent, and the need for ventilatory support is higher in this group compared to younger populations. Conclusion. Effective management of COVID-19 in elderly patients requires prompt diagnosis, tailored treatment strategies, and careful monitoring of complications. Further research is needed to develop more specific protocols for this vulnerable age group.
| Mualliflar | Муминов, С, Тулабоева, Г, Талипова, Ю, Мангосян, А, Абдукадирова, Н, Тоштемиров, Ж, Muminov , Solijon, Tulaboyeva , Gavhar, Talipova , Yulduz, Mangosaryan , Arsen, Abdukadirova , Nodira, Toshtemirov , Jahongir, Muminiv , Solijon, Tulaboyeva , Gavhar, Talipova , Yulduz, Mangosaryan , Arsen, Abdukadirova , Nodira, Toshtemirov , Jahongir |
|---|---|
| Jurnal | O‘zbekiston кardiologiyasi |
| Nashr sanasi | 2024-09-30 |
| Jild | 1 |
| Son | 3 |
| Betlar | 196-201 |
| Til | O‘zbek |
| DOI | 10.70626/cardiouz-2024-1-00023 |
DOI: 10.70626/cardiouz-2024-1-00023 · Maqolaning asl sahifasi
koronavirus (COVID-19),, keksa yoshdagi bemorlar, o‘tkir yallig‘lanish, surunkali yallig‘lanish, yurak-qon tomir kasalliklari, myocardial infarction, heart failure, neurohormones, revascularization, коронавирус (COVID-19), пожилые пациенты, острое воспаление, хроническое воспаление, сердечно-сосудистые заболевания
Background. Sodium-Glucose Cotransporter-2 (NGLT-2) inhibitors have gained significant attention for their cardioprotective properties. This review explores the cardiovascular benefits of NGLT-2 inhibitors…
The leading cause of death worldwide is cardiovascular disease. In addition to the known factors leading to CVD, in recent years much attention has been paid to obesity as one of the components of cardiometabolic…
Background. To study the characteristics of the clinical course of arterial hypertension by gender in the population of the Aral Sea region and to strengthen effective preventive measures. Materials and methods. The…
Background. Peripartum cardiomyopathy (PPCM) is a rare yet serious condition affecting women during late pregnancy or the postpartum period, often leading to complications such as ventricular arrhythmias and…
Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. Coronary artery disease (CAD) accounts for one third of all deaths from the diseases of the…
Abstract. Contrast-induced nephropathy (CIN) represents a significant clinical challenge, particularly among patients diagnosed with coronary artery disease (CAD) and type 2 diabetes mellitus (T2DM). The increased…
Background. Postoperative atrial fibrillation (POAF) is a common complication in patients undergoing coronary artery bypass grafting (CABG), which significantly affects recovery and increases the risk of adverse…
Arterial hypertension is a widely prevalent condition affecting millions of people worldwide. According to the World Health Organization (WHO) data, in 2021, more than 1 billion people suffered from hypertension. The…
Background.Reperfusion therapies, including primary percutaneous coronary intervention (PCI), thrombolysis, and salvage PCI, are crucial for treating patients with ST-segment elevation myocardial infarction (STEMI)…
Background. Atherosclerosis is a leading cause of cardiovascular mortality worldwide, significantly impacting public health. microRNA, as key regulators of gene expression, play a crucial role in the pathogenesis of…